Analytical Services for OINDPs
Pressurized metered dose inhalers (pMDI)
Dry powder inhalers (DPI)
Soft mist inhalers (SMI)
Nebulizers
Nasal sprays
Solvias Advantages
Accelerated Turnaround Time
The success of our customers is closely tied to time-to-market. We actively collaborate throughout the product development phase to design analytical testing plans that conform to regulatory standards, maintain the highest safety and quality benchmarks, and expedite product launches.
Our Technology
Solvias boasts impactors (NGI) and dosage unit sampling apparatus (DUSA) for inhaler performance assessment. Our automated systems (Vertus and DecaVertus) ensure reproducible testing outcomes, and our spray measurement systems (Sprayview and Spraytec) meet rigorous regulatory standards.
Regulatory Expertise
With vast experience in the inhalation sector, our team provides regulatory guidance to navigate the complex landscape of OINDP development. Our services are designed to meet FDA/EMA GMP requirements, supporting you through every step, from drug characterization to bioequivalence studies.
One-Stop Analytical Solution
The mastermind behind our OINDP capabilities
Contract Pharma recently interviewed Solvias’ team lead for drug delivery and physical characterization services, Yannick Baschung, PhD, who discussed the company’s OINDP capabilities, plans for future growth, as well as broader trends driving the OINDP market forward.